Technology News and Research

RSS

New molecular "clamps" offer powerful new tool for identifying individuals with increased risk of cancer

An international research team has built molecular "clamps" out of DNA that offer a powerful new tool for identifying individuals with an increased risk of cancer.

7 May 2014

Rice University researchers find new possibilities for benign, 'tunable' virus

Rice University scientists have designed a tunable virus that works like a safe deposit box. It takes two keys to open it and release its therapeutic cargo.

7 May 2014

New expert guidance encourages healthcare institutions to implement prevention efforts infectious diarrhea

With rates of Clostridium difficile (C. difficile) now rivaling drug-resistant Methicillin-resistant Staphylococcus aureus (MRSA) as the most common bacteria to cause healthcare-associated infections, new expert guidance encourages healthcare institutions to implement and prioritize prevention efforts for this infectious diarrhea.

7 May 2014

Scientists identify key molecular switches that control age-related memory impairment

Even among the healthiest individuals, memory and cognitive abilities decline with age. This aspect of normal aging can affect an individual's quality of life and capability to live independently but the rate of decline is variable across individuals.

7 May 2014

Grupo Casa Saba agrees to sell pharmacy retail business to Alliance Boots

Grupo Casa Saba, S.A.B. de C.V. announces that it has executed an agreement under which Alliance Boots will acquire GCS's pharmacy retail business for an equity value consideration of $8.3 billion Mexican pesos.

6 May 2014

ConvaTec posts strong financial results for FY 2013

ConvaTec, a privately-held medical products and technologies company, today announced strong financial results for the year ended December 31, 2013.

6 May 2014

Isis Pharmaceuticals reports pro forma net operating loss of $22.6 million for Q1 2014

Isis Pharmaceuticals, Inc. today reported a pro forma net operating loss (NOL) of $22.6 million for the three months ended March 31, 2014 compared to pro forma operating income of $4.5 million for the same period in 2013.

6 May 2014

GHX partners with PTC to help medical-surgical manufacturers

GHX today announced it has partnered with PTC (Nasdaq: PTC) to offer a solution to help medical-surgical manufacturers meet both commercial and regulatory compliance needs, including the submission requirements of the U.S. Food and Drug Administration's (FDA) new Unique Device Identification (UDI) rule.

6 May 2014

CathMaps+ world's first mobile application for people with elevated risk of cardiac incident

CathMaps+ will demonstrate how mobile technology can provide emergency assistance and peace of mind to millions of Americans at risk for a cardiac event.

6 May 2014

St. Bernards Healthcare selects InteliChart's Enterprise Patient Portal for acute care facilities

InteliChart, a leading provider of patient engagement and health information exchange (HIE) technology, announced today that St. Bernards Healthcare, the largest healthcare integrated delivery network in northeastern Arkansas, has selected InteliChart's Enterprise Patient Portal to deliver a single portal solution for its system of acute and ambulatory care facilities.

6 May 2014

Leading plastic surgeon invited to share latest advances in robotic hair restoration

Chicago plastic surgeon Gregory A. Turowski, MD, PhD, FACS, has been invited to be part of Harvard Medical School's "I Am Harvard," sharing his outcomes in the field of plastic surgery and advances in robotic hair restoration.

6 May 2014

Nanoviricides develops new drug candidates against MERS infection

...

6 May 2014

GIRAFF+: A robot carer in home

Our life expectancy lengthens and members of the 'silver generation' make up an ever-larger proportion of the population. Can technologies help us in caring for ourselves, our older relatives and friends? Could we learn to live together with robots while being watched over by sensors? The people behind one EU research project certainly think so.

6 May 2014

Phasefocus invited to present a two day workshop on label-free cell imaging at CATIM

Phase Focus Ltd (Phasefocus), the company that is revolutionising microscopy and imaging with the Phasefocus Virtual Lens®, has been invited to present a two day workshop on label-free cell imaging at CATIM – the Centre for Alternative Testing and In-vitro Monitoring on Tuesday 24th and Wednesday 25th June. The meeting will take place at the Frenchay Campus of the University of the West of England, Bristol.

From Phase Focus Limited 6 May 2014

Electronic system in hospital helps reduce medication errors in children

When children are admitted to the hospital, sometimes the medications they take at home are lost in the shuffle, or they may be given the wrong dose.

6 May 2014

Kinex receives FDA allowance for Oratecan anti-cancer drug irinotecan with enhanced oral absorption

Kinex Pharmaceuticals, Inc. announced today that the United States Food and Drug Administration (FDA) has allowed its Investigational New Drug (IND) application for Oratecan, an oral form of an approved anti-cancer drug irinotecan with enhanced oral absorption.

6 May 2014

Tufts licenses novel silk technology for treatment of chronic skin wounds to Akeso Biomedical

Tufts University today announced that it has licensed a novel silk technology for the treatment of chronic skin wounds to Akeso Biomedical, Inc., an early stage medical device company.

6 May 2014

Attorney of Colson Hicks Eidson files wrongful death complaint on behalf of passenger killed on Macarthur Causeway

Attorney Ervin A. Gonzalez, partner at the Coral Gables-based law firm Colson Hicks Eidson, filed a wrongful death complaint in the 11th Judicial Circuit Court in Miami-Dade County on behalf of the family of the late Dr. Malcolm Lloyd, passenger in the Lamborghini that was involved in a fatal car crash on April 24th on MacArthur Causeway.

6 May 2014

New phase III clinical trial shows non-invasive focused ultrasound treatment relieves cancer pain

When cancer progresses and spreads to the bone, patients often suffer debilitating pain. Now, a new phase III clinical trial shows that non-invasive magnetic resonance guided focused ultrasound treatment that heats the cancer within the bone, relieves pain and improves function for most patients when other treatment options are limited.

6 May 2014

ERYTECH Pharma gets authorization to initiate Phase II study in pancreatic cancer

ERYTECH Pharma, a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, announces that the ANSM, French healthcare agency, has granted the authorization to start a Phase II study in second line treatment of patients affected by pancreatic cancer.

6 May 2014

Technology News and Research

New molecular "clamps" offer powerful new tool for identifying individuals with increased risk of cancer

Rice University researchers find new possibilities for benign, 'tunable' virus

New expert guidance encourages healthcare institutions to implement prevention efforts infectious diarrhea

Scientists identify key molecular switches that control age-related memory impairment

Grupo Casa Saba agrees to sell pharmacy retail business to Alliance Boots

ConvaTec posts strong financial results for FY 2013

Isis Pharmaceuticals reports pro forma net operating loss of $22.6 million for Q1 2014

GHX partners with PTC to help medical-surgical manufacturers

CathMaps+ world's first mobile application for people with elevated risk of cardiac incident

St. Bernards Healthcare selects InteliChart's Enterprise Patient Portal for acute care facilities

Leading plastic surgeon invited to share latest advances in robotic hair restoration

Nanoviricides develops new drug candidates against MERS infection

GIRAFF+: A robot carer in home

Phasefocus invited to present a two day workshop on label-free cell imaging at CATIM

Electronic system in hospital helps reduce medication errors in children

Kinex receives FDA allowance for Oratecan anti-cancer drug irinotecan with enhanced oral absorption

Tufts licenses novel silk technology for treatment of chronic skin wounds to Akeso Biomedical

Attorney of Colson Hicks Eidson files wrongful death complaint on behalf of passenger killed on Macarthur Causeway

New phase III clinical trial shows non-invasive focused ultrasound treatment relieves cancer pain

ERYTECH Pharma gets authorization to initiate Phase II study in pancreatic cancer

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News